You sure look like an idiot don't you. You are a prime example of "why you shouldn't read message boards for investment advice" I wish Bsx did go down a few points on Wed. morning (and rebound)so you would have sold your shares. Remember the NIR is only one small piece of the pie that BSX offers.
The company missed earnings by one penny per share. Two things contributed to this Asian Markets and the delayed appoval. If these two items were on track the comapny would have blown wall street away. I am confident that the NIR will cause a blip that the traders were waiting for, but the company fundamentals will keep the equity high(er) for the long range shooters!
Just a thought. Only missed earnings by .01 without NIR stent. Had stent been approved as originally thought in June, would have blown numbers out of water. Sales are solid, remember Scimed is getting hurt w/o the stent, affecting bundling of other products. The Schneider deal was expensive, but the intellectual property that was purchased will pay back huge dividends long term. Schneider was not purchased for just sales! If stock dips, that is buying opportunity. Nir is key to Wall Street, performance will be graded more severely once stent is released. If NIR is a bust, then there is problems long term. Strret will react favorable to this earning s report. Shorters be careful, especially with the Nir approval around the corner.